Hepatic steatosis affects the outcome of anti-tuberculosis treatment in pulmonary tuberculosis patients

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · Published 2026-07-30 · DOI 10.1016/j.jctube.2026.100639

Free full text

Authors (3)

Gang Xue, Fang-Qun Chang, Zhi-Xiang Du

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Xue, G., Chang, F., Du, Z. (2026). Hepatic steatosis affects the outcome of anti-tuberculosis treatment in pulmonary tuberculosis patients. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. https://doi.org/10.1016/j.jctube.2026.100639

Related articles

• Developing an integrated medication event monitoring system and smartphone-based ecological momentary assessment delivery platform to identify real-time factors influencing TB treatment adherence in South Africa · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Performance of the BACES model in a Dutch cohort with nontuberculous mycobacterial pulmonary disease · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Epidemiological trajectories and predictive modeling of latent tuberculosis prevalence in South Asia: an in-depth global burden of disease analysis (1990–2021) with advanced forecasting to 2050 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Closing gaps through innovation in the tuberculosis pathology value chain · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Serum tuberculosis biomarkers and their association with clinical characteristics among hospitalized adults living with HIV in Uganda · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Knowledge, attitudes, and perceived barriers to tuberculosis care among patients and household contacts in Wolisso District, Oromia Region, Ethiopia · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2026 · Same journal
• Mycobacterium lentiflavum cutaneous pseudotumor in an immunosuppressed host · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2025 · Same journal
• Effectiveness and safety of the BPaL regimen in the Philippines · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 2025 · Same journal